ArticleNeurosurgical review2025
Association between endothelial activation and stress index and all-cause mortality in intensive care unit patients with intracerebral hemorrhage: A retrospective cohort study.
Article in Neurosurgical review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Endothelial Activation and Stress Index (EASIX) is a marker of endothelial dysfunction that could serve as a predictive tool for mortality in multiple disease. This study aimed to investigate the relationship between EASIX and all-cause mortality in patients with intracerebral hemorrhage (ICH) admitted to the intensive care unit (ICU).A retrospective cohort study was conducted using data from the MIMIC-IV database. The study included 838 ICH patients. Cox regression analysis was performed to assess the association between EASIX quartiles and mortality at 7, 30, 90, and 180 days. Kaplan-Meier survival curves and restricted cubic spline models were used to evaluate mortality risk across EASIX quartiles, and subgroup analyses were conducted to assess the consistency of findings across different patient groups.EASIX was significantly associated with increased mortality at all time points. Higher EASIX quartiles (Q4) were strongly correlated with higher mortality risk at 7 days (HR for Q4: 9.31), 30 days (HR for Q4: 3.85), 90 days (HR for Q4: 3.23), and 180 days (HR for Q4: 3.31) (p < 0.001 for all). Multivariate analysis confirmed that EASIX remained a significant predictor of mortality after adjusting for confounding factors such as age, sex, heart rate, mean blood pressure, SpO2, diabetes, myocardial infarct, congestive heart failure, renal disease, severe liver disease and chronic pulmonary disease. Subgroup analyses further indicated the robustness of these results.EASIX is a robust and reliable predictor of both short- and long-term mortality in ICH patients admitted to the ICU.
Indexed as
Identifiers
41307729What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.